ArticleNature communications2018
The chimeric TAC receptor co-opts the T cell receptor yielding robust anti-tumor activity without toxicity.
Christopher W Helsen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
72 papers cite itlatest 60 shown
this papercites it